Citation Impact
Citing Papers
Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective
2006
Blood Management
2007
Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery
2013
Cardiopulmonary exercise testing and survival after elective abdominal aortic aneurysm repair
2014
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
Surgical Prehabilitation in Patients with Cancer
2016
Hyperglycaemia and pulmonary infection
2006
Safety of Recombinant Activated Factor VII in Randomized Clinical Trials
2010
Efficacy and Safety of Recombinant Activated Factor VII in Major Surgical Procedures
2008
Patients with poor baseline walking capacity are most likely to improve their functional status with multimodal prehabilitation
2016
Preoperative exercise therapy in surgical care: a scoping review
2016
Off-Label Recombinant Factor VIIa Use and Thrombosis in Children: A Multi-Center Cohort Study
2010
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Efficacy and Safety of Recombinant Activated Factor VII to Control Bleeding in Nonhemophiliac Patients: A Review of 17 Randomized Controlled Trials
2008
Alkaloids: An overview of their antibacterial, antibiotic-enhancing and antivirulence activities
2014 Standout
Massive transfusion and nonsurgical hemostatic agents
2008
Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation
2014 Standout
Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data
2008
Recombinant Activated Factor VII: A Solution to Refractory Haemorrhage in Vascular Surgery?
2007
2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary
2014
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Enhanced Recovery After Surgery
2017 Standout
2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery
2014
2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary
2014
Inflammatory Mechanisms in Obesity
2011 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
A rare case of strychnine poisoning by consumption of Strychnos nux-vomica leaves
2011
Prehabilitation versus Rehabilitation
2014
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Promoting Perioperative Metabolic and Nutritional Care
2015
Damage Control Resuscitation
2014
Works of J Redman being referenced
Impaired functional capacity is associated with all-cause mortality after major elective intra-abdominal surgery
2010
Strychnine poisoning: gone but not forgotten
2010
Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial † †This article is accompanied by the Editorial. ‡ ‡Declaration of interest. R. M. Grounds has worked in the past as a consultant for Novo Nordisk and has lectured at symposiums organized by Novo Nordisk. Novo Nordisk has given an unrestricted educational grant to St George’s Hospital Special Trustee’s. The trial was funded by Novo Nordisk, UK.
2005
Factors determining the appearance of glucose in upper and lower respiratory tract secretions
2003